SEATTLE--(BUSINESS WIRE)--Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercodeâ„¢ WT Penta and Penta 384, the first single cell RNA sequencing ...
Parse Biosciences, a QIAGEN company (NYSE: QGEN, Frankfurt Prime Standard: QIA), and the leading provider of scalable and ...
Parse’s GigaLab to provide industry leading, large-scale, single cell services to support Tahoe’s development of foundational biological datasets Parse Biosciences, a leading provider of accessible ...
Tahoe Therapeutics – a biotech start-up based in San Francisco, California – is creating the largest ever atlas of ...
Tahoe Therapeutics - a biotech start-up based in San Francisco, California - is creating the largest ever atlas of ...
Parse Biosciences today announced their commitment to support researchers from the Icahn School of Medicine at Mount Sinai in generating one of the largest single cell datasets focused on ...
Collaboration pairs robust synthetic biology platform with massive scale single cell sequencing to overcome long-standing challenges in variant mapping Parse Biosciences, the leading provider of ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus ...